ResearcherFirst Affiliated Hospital Zhejiang UniversityNo recent work listed

Xiangming Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5173-2987; OpenAlex author ID A5101585623. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2019: 2 papers

Papers 2

Combined detection of CA19-9 and B7-H4 in the diagnosis and prognosis of pancreatic cancer. Co-author DOI 10.3233/cbm-190067 ↗
Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pa… First author DOI 10.3389/fonc.2019.01377 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bo Hong · 2 shared papers, 2019 · strength 0.22
- Paper Combined detection of CA19-9 and B7-H4 in the diagnosis and prognosis of pancreatic cancer. DOI 10.3233/cbm-190067 ↗
- Paper Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Tar… DOI 10.3389/fonc.2019.01377 ↗
Yun Qian · 2 shared papers, 2019 · strength 0.22
- Paper Combined detection of CA19-9 and B7-H4 in the diagnosis and prognosis of pancreatic cancer. DOI 10.3233/cbm-190067 ↗
- Paper Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Tar… DOI 10.3389/fonc.2019.01377 ↗
Hangping Yao · 1 shared paper, 2019 · strength 0.09
- Paper Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Tar… DOI 10.3389/fonc.2019.01377 ↗
Ming‐Hai Wang · 1 shared paper, 2019 · strength 0.09
- Paper Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Tar… DOI 10.3389/fonc.2019.01377 ↗
Chenyu W Hu · 1 shared paper, 2019 · strength 0.09
- Paper Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Tar… DOI 10.3389/fonc.2019.01377 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.